NICE lipid modification guidance amended

Computer artwork of blood cells (round) in an artery affected by atherosclerosis. | SPL
Computer artwork of blood cells (round) in an artery affected by atherosclerosis. | SPL

The NICE Lipid Modification guideline (CG67) has been amended so that the Framingham risk equation is no longer the equation of choice for the assessment of cardiovascular disease (CVD) risk. The guideline now states that the QRISK or ASSIGN equations as well as the Framingham equation can be used to calculate the CVD risk. There are no changes to the categories of risk recommended for treatment or in whom the equations should be used to calculate the risk.

View MIMS summary of NICE Lipid Modification guideline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Find alternatives to out-of-stock products with MIMS tables

Find alternatives to out-of-stock products with MIMS tables

With a recent increase in the number of drugs in short...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

New buprenorphine injection allows weekly or monthly treatment of opioid dependence

New buprenorphine injection allows weekly or monthly treatment of opioid dependence

Buvidal (buprenorphine) is licensed for the treatment...

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.